Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease.
- DOI
- 10.1016/j.ejmech.2026.119350
- Published
- 2026 Sep 19
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.119350,
title = {Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease.},
author = {Ye J and Yin S and Lin Y and Yang S and Ma L and Wang Y and Gao K and Wang Y and Yang X and Yang Z and Wang N and Liu H and Xu S and Cui W and Zhang B},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.119350},
url = {https://doi.org/10.1016/j.ejmech.2026.119350}
}RIS
TY - JOUR TI - Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease. AU - Ye J AU - Yin S AU - Lin Y AU - Yang S AU - Ma L AU - Wang Y AU - Gao K AU - Wang Y AU - Yang X AU - Yang Z AU - Wang N AU - Liu H AU - Xu S AU - Cui W AU - Zhang B PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.119350 UR - https://doi.org/10.1016/j.ejmech.2026.119350 ER -
APA
J, Y., S, Y., Y, L., S, Y., L, M., Y, W., K, G., Y, W., X, Y., Z, Y., N, W., H, L., S, X., W, C., & B, Z. (2026). Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119350
Source records
- pubmed · retrieved 2026-09-26T08:36:15.970Z